A federal appeals court in Washington, D.C. has dismissed a Fisher & Paykel Healthcare (NZE:FPH) appeal of a breathing masks patent decision involving ResMed (NYSE:RMD). The two companies already settled all outstanding patent infringement disputes worldwide in a deal announced in February, with Resmed then seeking to dismiss Fisher & Paykel’s appeal of the U.S. Patent […]
ResMed surges on fiscal Q1 beats
ResMed (NYSE:RMD) shares surged in premarket trading today after the respiratory company posted fiscal first-quarter numbers that topped the consensus forecast. San Diego-based ResMed posted profits of $120.1 million, or 83¢ per share, on sales of $681.1 million for the three months ended Sept. 30, for a 13.6% bottom-line gain on sales growth of 15.8%. Adjusted […]
ResMed reveals tentative $40m settlement with feds
ResMed (NYSE:RMD) last week revealed a tentative, $40 million settlement with the U.S. Justice Dept. to resolve a three-year probe into its resupply business. The San Diego-based respiratory company said it set aside $41.2 million to cover the $39.5 million settlement and any legal and administrative costs. In July 2016 the Justice Dept. subpoenaed ResMed for […]
ResMed gains on fiscal Q4 beats
ResMed (NYSE:RMD) shares are up today just before the market’s open on fiscal fourth-quarter results that topped analysts’ expectations. The San Diego-based respiratory devices maker reported profits of $68.8 million, or 48¢ per share, on sales of $705.0 million for the three months ended June 30, for a bottom-line slide of -37.3% on sales growth of […]
ResMed study shows 170 million in Americas have sleep apnea
More than 170 million people in North and South America have sleep apnea, according to a new study released today by apnea device-maker ResMed (NYSE:RMD). The company reached the 170 million figure based on the American Academy of Sleep Medicine (AASM) 2012 criteria and termed it a “conservative” estimate. The figure represents 37% of adults […]
ResMed shares up after posting Street-beating Q3
Shares in ResMed (NYSE:RMD) are up after the medical device maker posted third-quarter results that beat the consensus on Wall Street. The San Diego-based company reported profits of $105.4 million, or 73¢ per share, on sales of $662.2 million for the three months ended March 31, for a 12% growth in sales and a profit loss of […]
ResMed buys Korean home healthcare supplier HB Healthcare
ResMed (NYSE:RMD) said today that it bought Korean home healthcare equipment supplier HB Healthcare for an undisclosed amount. San Diego-based ResMed said the acquisition is aimed at extending its decade-old footprint in South Korea to “millions more patients through HBH and its wider network of trusted distributor partners.” “ResMed has reaffirmed its leading role in Korea’s […]
At-home digital health: Here’s what you need to know
Demand is increasing for at-home digital health systems, where sensors follow people’s health data and automatically turn them into real-time insights for themselves and their health providers. From ResMed and its connected CPAP technology to Clarify Medical getting user feedback for its light therapy system for skin conditions, medical device companies have started to score […]
Propeller Health study suggests 84% of asthma inhaler use performed incorrectly
ResMed (NYSE:RMD) subsidiary Propeller Health today released results from a new study exploring real-world use of rescue or controller inhalers that indicated that the majority of users did not use their inhalers properly. Results from the research were published in The Journal of Allergy and Clinical Immunology: In Practice, the Madison, Wisc.-based company said. Read the whole story on […]
ResMed, Fisher & Paykel agree to settle all outstanding patent suits
ResMed (NYSE:RMD) and Fisher & Paykel Healthcare (NZE:FPH) said today in a joint announcement that they have reached an agreement to settle all outstanding patent infringement disputes across all global venues. While the terms of the deal remain confidential, both San Diego-based ResMed and Auckland, New Zealand-based Fisher & Paykel said it involved no payments from either party. […]
Propeller, Orion to develop digital asthma, COPD therapy
Propeller Health said today that it inked a deal to connect Orion’s Easyhaler line of inhalers for asthma and COPD with Propeller’s digital medicine platform. The two companies plan to co-develop a sensor that will attach to Orion’s inhalers and pair with a mobile app. Get the full story at our sister site, Drug Delivery Business […]
- 1
- 2
- 3
- …
- 10
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube